Literature DB >> 15031319

Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.

Christian Opherk1, François Tronche, Christoph Kellendonk, Dirk Kohlmüller, Andreas Schulze, Wolfgang Schmid, Günther Schütz.   

Abstract

Hepatic glucose production by gluconeogenesis is the main source of glucose during fasting and contributes significantly to hyperglycemia in diabetes mellitus. Accordingly, glucose metabolism is tightly controlled by a variety of hormones including insulin, epinephrine, glucagon, and glucocorticoids (GCs) acting on various cell types. GC effects are mediated by the GC receptor (GR), a ligand-dependent transcription factor, which in the liver and kidney controls gluconeogenesis by induction of gluconeogenic enzymes. To specifically study the contribution of GC on liver carbohydrate metabolism, we generated mice with an inactivation of the GR gene exclusively in hepatocytes using the Cre/loxP technology. Half of the mutant mice die within the first 2 d after birth most likely due to hypoglycemia. Adult mice have normal blood sugar under basal conditions but show hypoglycemia after prolonged starvation due to reduced expression of genes involved in gluconeogenesis. We further demonstrate that absence of GR in hepatocytes limits the development of hyperglycemia in streptozotocin-induced diabetes mellitus probably due to impaired induction of gluconeogenesis. These findings show the essential role of GR function in liver glucose metabolism during fasting and in diabetic mice and indicate that liver-specific GC antagonists could be beneficial in control of diabetic hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031319     DOI: 10.1210/me.2003-0283

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  65 in total

1.  Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.

Authors:  Kang Ho Kim; Jae Man Lee; Ying Zhou; Sanjiv Harpavat; David D Moore
Journal:  Mol Endocrinol       Date:  2016-06-29

2.  Structures and mechanism for the design of highly potent glucocorticoids.

Authors:  Yuanzheng He; Wei Yi; Kelly Suino-Powell; X Edward Zhou; W David Tolbert; Xiaobo Tang; Jing Yang; Huaiyu Yang; Jingjing Shi; Li Hou; Hualiang Jiang; Karsten Melcher; H Eric Xu
Journal:  Cell Res       Date:  2014-04-25       Impact factor: 25.617

3.  Cistromic Reprogramming of the Diurnal Glucocorticoid Hormone Response by High-Fat Diet.

Authors:  Fabiana Quagliarini; Ashfaq Ali Mir; Kinga Balazs; Michael Wierer; Kenneth Allen Dyar; Celine Jouffe; Konstantinos Makris; Johann Hawe; Matthias Heinig; Fabian Volker Filipp; Grant Daniel Barish; Nina Henriette Uhlenhaut
Journal:  Mol Cell       Date:  2019-11-06       Impact factor: 17.970

4.  Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes.

Authors:  Sanna-Mari Aatsinki; Mahmoud-Sobhy Elkhwanky; Outi Kummu; Mikko Karpale; Marcin Buler; Pirkko Viitala; Valtteri Rinne; Maija Mutikainen; Pasi Tavi; Andras Franko; Rudolf J Wiesner; Kari T Chambers; Brian N Finck; Jukka Hakkola
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

Review 5.  Epigenomic and transcriptional control of insulin resistance.

Authors:  E D Rosen
Journal:  J Intern Med       Date:  2016-10-14       Impact factor: 8.989

6.  Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Authors:  Y Wang; Y Nakagawa; L Liu; W Wang; X Ren; A Anghel; K Lutfy; T C Friedman; Y Liu
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

7.  Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis.

Authors:  Robin Winkler; Verena Benz; Markus Clemenz; Mandy Bloch; Anna Foryst-Ludwig; Sami Wardat; Nicole Witte; Manuela Trappiel; Pawel Namsolleck; Knut Mai; Joachim Spranger; Gabriele Matthias; Tim Roloff; Oliver Truee; Kai Kappert; Michael Schupp; Patrick Matthias; Ulrich Kintscher
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

8.  Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.

Authors:  Sandip K Bose; Irina Hutson; Charles A Harris
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

9.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

10.  Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.

Authors:  Raoul Frijters; Wilco Fleuren; Erik J M Toonen; Jan P Tuckermann; Holger M Reichardt; Hans van der Maaden; Andrea van Elsas; Marie-Jose van Lierop; Wim Dokter; Jacob de Vlieg; Wynand Alkema
Journal:  BMC Genomics       Date:  2010-06-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.